Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)

Circulation

Volumn 111, Issue 18, 2005, Pages 2299-2305

  Empana, J P ^a,b   Sykes, D H ^c   Luc, G ^d   Juhan Vague, I ^a   Arveiler, D ^e   Ferrieres, J ^a   Amouyel, P ^d   Bingham, A ^b   Montaye, M ^d   Ruidavets, J B ^a   Haas, B ^e   Evans, A ^c   Jouven, X ^a,b,f   Ducimetiere, P ^b  

^a INSERM   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Coronary disease; Depressive disorder; Epidemiology; Inflammation; Risk factors

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEPRESSION; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; EXERCISE TEST; FOLLOW UP; FRANCE; HEART DEATH; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCINTIGRAPHY; SOCIAL STATUS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY DISEASE; DEPRESSIVE DISORDER; EUROPE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 20844462584     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000164203.54111.AE     Document Type: Article

References (31)

1. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 1993;4:285-294.
2. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men: the Precursors Study. Arch Intern Med. 1998;158:1422-1426.
3. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation. 1996; 94:3123-3129.
4. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996; 93:1976-1980.
5. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study: National Health and Nutrition Examination Survey. Arch Intern Med. 2000;160:1261-1268.
6. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med. 2003;65:201-210.
7. Rugulies R. Depression as a predictor for coronary heart disease, a review and meta-analysis. Am J Prev Med. 2002;23:51-61.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
9. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
10. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984-1992. Circulation. 1999;99:237-242.
11. Luc G , Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, Arveiler D, Fruchart JC, Ducimetiere P, for the PRIME Study Group. C-reactive protein, interleukin-6, and fibrinogen as predictor of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol. 2003; 23:1255-1261.
12. PM Ridker, CH Hennekens, B Roitman-Johnson, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88-92.
13. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, Elkhalil L, Fruchart JC, Ducimetiere P, for the PRIME Study Group. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis. 2003;170:169-176.
14. H Tiemeier, A Hofman, H Ruud van Tuijl, Kiliaan AJ, Meijer J, Breteler MM. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14:103-107.
15. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004;164:1010-1014.
16. GE Miller, CA Stetler, RM Carney, Freedland KE, Banks WA. Clinical depression and inflammatory markers for coronary heart disease. Am J Cardiol. 2002;90:1279-1283.
17. Dentino AN, Pieper CF, Rao KMK, Currie MS, Harris T, Blazer DG, Cohen HJ. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 1999;47:6-11.
18. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition Study. Biol Psychiatry. 2003;54:566-572.
19. Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, Stefanadis C, for the ATTICA Study. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people: the ATTICA study. Eur Heart J. 2004;25:492-499.
20. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, Newman A, Hirsch C, Tracy RP. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89:419-424.
21. Steptoe A, Kunz-Ebrecht SR, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med. 2003;33:667-674.
22. Broadley AJM, Korszun A, Jones CJH, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart. 2002;88:521-523.
23. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol. 2001;88:196-198, A7.
24. Yarnell JW. The PRIME Study: classical risk factors do not explain the several fold differences in risk of coronary heart disease between France and Northern Ireland: Prospective Epidemiological Study of Myocardial Infarction. QJM. 1998;91:667-676.
25. Ducimetiere P, Ruidavets JB, Montaye M, Haas B, Yarnell J, for the PRIME Study Group. Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Int J Epidemiol. 2001;30:1057-1062.
26. Sykes DH, Arveiler D, Salters CP, Ferrieres J, McCrum E, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Ducimetiere P, Evans AE. Psychosocial risk factors for heart disease in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Int J Epidemiol. 2002;31:1227-1234.
27. Rodda BE, Miller MC 3rd, Bruhn JG. Prediction of anxiety and depression patterns among coronary patients using a Markov process analysis. Behav Sci. 1971;16:482-489.
28. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
29. Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation. 2001;103:1933-1935.
30. Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry. 2004;161:271-277.
31. Lewis MR, Callas PW, Jenny NS, Tracy RP. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost. 2001;86:1495-1500.